Anti-RIMS2 monoclonal antibody

Pre-made anti-RIMS2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to RIMS2/RIMS2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2707-Ab-1/ GM-Tg-hg-IP2707-Ab-2Anti-Human RIMS2 monoclonal antibodyHuman
GM-Tg-rg-IP2707-Ab-1/ GM-Tg-rg-IP2707-Ab-2Anti-Rat RIMS2 monoclonal antibodyRat
GM-Tg-mg-IP2707-Ab-1/ GM-Tg-mg-IP2707-Ab-2Anti-Mouse RIMS2 monoclonal antibodyMouse
GM-Tg-cynog-IP2707-Ab-1/ GM-Tg-cynog-IP2707-Ab-2Anti-Cynomolgus/ Rhesus macaque RIMS2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2707-Ab-1/ GM-Tg-felg-IP2707-Ab-2Anti-Feline RIMS2 monoclonal antibodyFeline
GM-Tg-cang-IP2707-Ab-1/ GM-Tg-cang-IP2707-Ab-2Anti-Canine RIMS2 monoclonal antibodyCanine
GM-Tg-bovg-IP2707-Ab-1/ GM-Tg-bovg-IP2707-Ab-2Anti-Bovine RIMS2 monoclonal antibodyBovine
GM-Tg-equg-IP2707-Ab-1/ GM-Tg-equg-IP2707-Ab-2Anti-Equine RIMS2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2707-Ab-1/ GM-Tg-hg-IP2707-Ab-2; GM-Tg-rg-IP2707-Ab-1/ GM-Tg-rg-IP2707-Ab-2;
GM-Tg-mg-IP2707-Ab-1/ GM-Tg-mg-IP2707-Ab-2; GM-Tg-cynog-IP2707-Ab-1/ GM-Tg-cynog-IP2707-Ab-2;
GM-Tg-felg-IP2707-Ab-1/ GM-Tg-felg-IP2707-Ab-2; GM-Tg-cang-IP2707-Ab-1/ GM-Tg-cang-IP2707-Ab-2;
GM-Tg-bovg-IP2707-Ab-1/ GM-Tg-bovg-IP2707-Ab-2; GM-Tg-equg-IP2707-Ab-1/ GM-Tg-equg-IP2707-Ab-2
Products NameAnti-RIMS2 monoclonal antibody
Formatmab
Target NameRIMS2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-RIMS2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2707-Ag-1Recombinant multi-species RIMS2/ OBOE/ RAB3IP3 protein


    Target information

    Target IDGM-IP2707
    Target NameRIMS2
    Gene ID9699,116838,116839,694366,475066,101080764,535674,100062793
    Gene Symbol and Synonyms2810036I15Rik,CRSDS,mKIAA0751,Nim2,OBOE,Rab3ip2,RAB3IP3,RIM2,Rim2(+40A),Rim2(+44A),Rim2(+4A),RIMS2,Serg2,Syt3-rs
    Uniprot AccessionQ9UQ26,Q9JIS1
    Uniprot Entry NameRIMS2_HUMAN,RIMS2_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000176406
    Target ClassificationN/A

    The target: RIMS2, gene name: RIMS2, also named as OBOE, RAB3IP3, RIM2. The protein encoded by this gene is a presynaptic protein that interacts with RAB3, a protein important for normal neurotransmitter release. The encoded protein can also bind several other synaptic proteins, including UNC-13 homolog B, ELKS/Rab6-interacting/CAST family member 1, and synaptotagmin 1. This protein is involved in synaptic membrane exocytosis. Polymorphisms in this gene have been associated with degenerative lumbar scoliosis. [provided by RefSeq, Feb 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.